ECSP10010498A - Procesos para la preparación de derivados de heteroarilo benzofusionados - Google Patents

Procesos para la preparación de derivados de heteroarilo benzofusionados

Info

Publication number
ECSP10010498A
ECSP10010498A EC2010010498A ECSP10010498A ECSP10010498A EC SP10010498 A ECSP10010498 A EC SP10010498A EC 2010010498 A EC2010010498 A EC 2010010498A EC SP10010498 A ECSP10010498 A EC SP10010498A EC SP10010498 A ECSP10010498 A EC SP10010498A
Authority
EC
Ecuador
Prior art keywords
processes
preparation
benzofused
derivatives
heteroarilo
Prior art date
Application number
EC2010010498A
Other languages
English (en)
Inventor
Laura M Reany
Scott A Ballentine
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ECSP10010498A publication Critical patent/ECSP10010498A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)

Abstract

La presente invención se dirige a los procesos para la preparación de derivados de heteroarilo benzofusionados, útiles para el tratamiento de la epilepsia y trastornos relacionados. La presente invención se dirige, además, a los procesos para la preparación de productos intermedios en la síntesis de derivados de heteroarilo benzofusionados.
EC2010010498A 2008-03-26 2010-09-24 Procesos para la preparación de derivados de heteroarilo benzofusionados ECSP10010498A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2008/058247 WO2009120192A2 (en) 2008-03-26 2008-03-26 Process for the preparation of benzo-fused heteroaryl derivatives

Publications (1)

Publication Number Publication Date
ECSP10010498A true ECSP10010498A (es) 2010-10-30

Family

ID=40351717

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2010010498A ECSP10010498A (es) 2008-03-26 2010-09-24 Procesos para la preparación de derivados de heteroarilo benzofusionados

Country Status (13)

Country Link
EP (1) EP2280951A2 (es)
JP (1) JP2011517448A (es)
KR (1) KR20100126536A (es)
CN (1) CN101981023A (es)
AU (1) AU2008353492A1 (es)
BR (1) BRPI0822396A2 (es)
CA (1) CA2719402A1 (es)
EA (1) EA201071121A1 (es)
EC (1) ECSP10010498A (es)
IL (1) IL208223A0 (es)
MX (1) MX2010010597A (es)
WO (1) WO2009120192A2 (es)
ZA (1) ZA201007610B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
JP2008545650A (ja) 2005-05-20 2008-12-18 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ スルファミド誘導体の製造方法
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
EP2026790A2 (en) 2006-05-19 2009-02-25 Janssen Pharmaceutica, N.V. Co-therapy for the treatment of epilepsy and related disorders
US8809385B2 (en) * 2008-06-23 2014-08-19 Janssen Pharmaceutica Nv Crystalline form of (2S)-(-)-N-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
CA2850513A1 (en) 2011-09-29 2013-04-04 Janssen Pharmaceutica Nv Process for the preparation of sulfamide derivatives
WO2013045681A1 (en) * 2011-09-29 2013-04-04 Janssen Pharmaceutica Nv Improved process for the preparation of sulfamide derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120758A (en) * 1991-02-08 1992-06-09 Ciba-Geigy Corporation Certain benzodioxole, benzodioxane and benzodioxepin derivatives useful as 5-lipoxygenase inhibitors
MY147767A (en) * 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders

Also Published As

Publication number Publication date
JP2011517448A (ja) 2011-06-09
AU2008353492A1 (en) 2009-10-01
WO2009120192A2 (en) 2009-10-01
EP2280951A2 (en) 2011-02-09
MX2010010597A (es) 2010-10-25
CN101981023A (zh) 2011-02-23
BRPI0822396A2 (pt) 2019-09-24
WO2009120192A3 (en) 2010-01-21
IL208223A0 (en) 2010-12-30
EA201071121A1 (ru) 2011-04-29
CA2719402A1 (en) 2009-10-01
ZA201007610B (en) 2012-04-25
KR20100126536A (ko) 2010-12-01

Similar Documents

Publication Publication Date Title
ECSP10010498A (es) Procesos para la preparación de derivados de heteroarilo benzofusionados
BRPI0810198A2 (pt) Processo para produzir composto de amida
AR075291A1 (es) Proceso para la preparcion de derivados de l-alanina protegidos
BR112013003819A2 (pt) método para a síntese de moleculas contendo furano de fórmula i a partir de moléculas contendo furano de fórmula ii
BRPI0817909A2 (pt) Intermediários e métodos para a síntese de análogos de halicondrina
ECSP10010582A (es) Derivados de aminodihidrotiazina como inhibidores de bace para el tratamiento de la enfermedad de alzheimer
CR11161A (es) Procesos para la produccion de pirazoles
BR112013002925A2 (pt) processo para a síntese de ácido 2,5-furandicarboxílico
CR20140554A (es) Compuestos de acido dimetil-benzoico
CR11761A (es) Proceso para la preparacion de sulfamatos de heteroarilo benzofusionado y la forma cristalina de n-(((2s)-6-cloro-2,3-dihidro-1,4-benzodioxin-2il)metil-sulfamida
CR20140553A (es) Compuestos de fenoxietil piperidina
ECSP099070A (es) Bencilaminas, un proceso para su producción y su uso como agentes anti-inflamatorios
ECSP13012914A (es) Síntesis de derivados de 2-carboxamida-cicloamino-urea
BRPI0920435A2 (pt) processo para produzir gás de síntese de amônia.
DK2137192T3 (da) Derivater af galantamin som prodrugs til behandling af humane hjernesygdomme
CL2012003371A1 (es) Compuestos intermediarios de la síntesis de agomelatina; y el procedimiento de obtención de agomelatina a partir de dichos compuestos intermediarios
BRPI1008117A2 (pt) Processo para a sintese de cleistantina
CR20110208A (es) Proceso para la preparación de benzonorbornenos
EA201170481A1 (ru) Сокристаллы
PA8796801A1 (es) Sintesis quiral de diazepinoquinolinas
BRPI0914400A2 (pt) "processo para a síntese de um composto"
BRPI0909327A2 (pt) Processo para a produção de gás de síntese
AR058253A1 (es) Procedimiento para la preparacion de ferri-succinilcaseina
BR112013024193A2 (pt) método para a produção de uma estrutura útil para a produção de um gerador termelétrico, estutura útil, gerador termelétrico
GT200900215A (es) Nuevo procedimiento de obtencion de la forma cristalina v de la agomelatina.